The DOI matches its Crossref record; 28 of the 28 references it cites were found in a registry or an index.
Calreticulin, a Peptide-binding Chaperone of the Endoplasmic Reticulum, Elicits Tumor- and Peptide-specific Immunity
Open accessAbstract
Calreticulin (CRT), a peptide-binding heat shock protein (HSP) of the endoplasmic reticulum (ER), has been shown previously to associate with peptides transported into the ER by transporter associated with antigen processing (Spee, P., and J. Neefjes. 1997. Eur. J. Immunol. 27: 2441–2449). Our studies show that CRT preparations purified from tumors elicit specific immunity to the tumor used as the source of CRT but not to an antigenically distinct tumor. The immunogenicity is attributed to the peptides associated with the CRT molecule and not to the CRT molecule per se. It is further shown that CRT molecules can be complexed in vitro to unglycosylated peptides and used to elicit peptide-specific CD8+ T cell response in spite of exogenous administration. These characteristics of CRT closely resemble those of HSPs gp96, hsp90, and hsp70, although CRT has no apparent structural homologies to them.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Walker, J. E., Saraste, M., Runswick, M. J., & Gay, N. J. (1982) · The EMBO Journal · doi:10.1002/j.1460-2075.1982.tb01276.x · Cited by 5,312
A Mechanism for the Specific Immunogenicity of Heat Shock Protein-Chaperoned Peptides
Suto, R., & Srivastava, P. K. (1995) · Science · doi:10.1126/science.7545313 · Cited by 823
Self-citationSadasivan, B., Lehner, P. J., Ortmann, B., Spies, T., & Cresswell, P. (1996) · Immunity · doi:10.1016/s1074-7613(00)80487-2 · Cited by 700
Heat shock protein 70-associated peptides elicit specific cancer immunity.
Udono, H., & Srivastava, P. K. (1993) · The Journal of experimental medicine · doi:10.1084/jem.178.4.1391 · Cited by 621
Self-citationHeat shock proteins transfer peptides during antigen processing and CTL priming
Srivastava, P., Udono, H., Blachere, N., & Li, Z. (1994) · Immunogenetics · doi:10.1007/bf00188611 · Cited by 569
Self-citationBlachere, N. E., Li, Z., Chandawarkar, R. Y., Suto, R., Jaikaria, N. S., Basu, S., Udono, H., & Srivastava, P. K. (1997) · The Journal of Experimental Medicine · doi:10.1084/jem.186.8.1315 · Cited by 556
Self-citationTumor rejection antigens of chemically induced sarcomas of inbred mice.
Srivastava, P. K., DeLeo, A. B., & Old, L. J. (1986) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.83.10.3407 · Cited by 457
Self-citationWare, F. E., Vassilakos, A., Peterson, P. A., Jackson, M. R., Lehrman, M. A., & Williams, D. B. (1995) · Journal of Biological Chemistry · doi:10.1074/jbc.270.9.4697 · Cited by 419
Comparison of tumor-specific immunogenicities of stress-induced proteins gp96, hsp90, and hsp70.
Udono, H., & Srivastava, P. K. (1994) · The Journal of Immunology · doi:10.4049/jimmunol.152.11.5398 · Cited by 401
Self-citationUdono, H., Levey, D. L., & Srivastava, P. K. (1994) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.91.8.3077 · Cited by 347
Self-citationArnold, D., Faath, S., Rammensee, H., & Schild, H. (1995) · The Journal of experimental medicine · doi:10.1084/jem.182.3.885 · Cited by 330
A mouse tumor-specific transplantation antigen is a heat shock-related protein.
Ullrich, S. J., Robinson, E. A., Law, L. W., Willingham, M., & Appella, E. (1986) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.83.10.3121 · Cited by 288
Li, Z., & Srivastava, P. K. (1993) · The EMBO Journal · doi:10.1002/j.1460-2075.1993.tb05983.x · Cited by 285
Self-citationNigam, S. K., Goldberg, A. L., Ho, S., Rohde, M. F., Bush, K. T., & Sherman, M. (1994) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(17)42090-4 · Cited by 282
Ishii, T., Udono, H., Yamano, T., Ohta, H., Uenaka, A., Ono, T., Hizuta, A., Tanaka, N., Srivastava, P. K., & Nakayama, E. (1999) · The Journal of Immunology · doi:10.4049/jimmunol.162.3.1303 · Cited by 235
Self-citationER-60, a chaperone with thiol-dependent reductase activity involved in MHC class I assembly
Lindquist, J. A. (1998) · The EMBO Journal · doi:10.1093/emboj/17.8.2186 · Cited by 231
Nieland, T. J., Tan, M. C., Monne-van Muijen, M., Koning, F., Kruisbeek, A. M., & van Bleek, G. M. (1996) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.93.12.6135 · Cited by 216
The thiol oxidoreductase ERp57 is a component of the MHC class I peptide-loading complex
Hughes, E. A., & Cresswell, P. (1998) · Current Biology · doi:10.1016/s0960-9822(98)70278-7 · Cited by 189
Ciupitu, A.-M. T., Petersson, M., O'Donnell, C. L., Williams, K., Jindal, S., Kiessling, R., & Welsh, R. M. (1998) · The Journal of Experimental Medicine · doi:10.1084/jem.187.5.685 · Cited by 188
(1993) · Advances in Cancer Research · doi:10.1016/s0065-230x(08)60318-8 · Cited by 166
Spee, P., & Neefjes, J. (1997) · European Journal of Immunology · doi:10.1002/eji.1830270944 · Cited by 161
Dierks, T., Volkmer, J., Schlenstedt, G., Jung, C. K. E., Sandholzer, U., Zachmann, K., Schlotterhose, P., Neifer, K., Schmidt, B., & Zimmermann, R. (1996) · The EMBO Journal · doi:10.1002/j.1460-2075.1996.tb01085.x · Cited by 127
Srivastava, P. K., & Heike, M. (1991) · PubMed · Cited by 102
Self-citationSrivastava, P. K., & Das, M. R. (1984) · International Journal of Cancer · doi:10.1002/ijc.2910330321 · Cited by 101
Self-citationArnold, D., Wahl, C., Faath, S., Rammensee, H., & Schild, H. (1997) · The Journal of Experimental Medicine · doi:10.1084/jem.186.3.461 · Cited by 87
Expression of a shared tumor-specific antigen by two chemically induced BALB/c sarcomas.
Palladino, M. A., Srivastava, P. K., Oettgen, H. F., & DeLeo, A. B. (1987) · PubMed · Cited by 80
Self-citationvan Leeuwen, J. E. M., & Kearse, K. P. (1996) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.93.24.13997 · Cited by 80
Molecular heterogeneity of tumor rejection antigen/heat shock protein GP96
Feldweg, A. M., & Srivastava, P. K. (1995) · International Journal of Cancer · doi:10.1002/ijc.2910630227 · Cited by 55
Self-citation
Cited by
Calreticulin exposure dictates the immunogenicity of cancer cell death
Obeid, M., Tesniere, A., Ghiringhelli, F., Fimia, G. M., Apetoh, L., Perfettini, J.-L., Castedo, M., Mignot, G., Panaretakis, T., Casares, N., et al. (2007) · Nature Medicine · doi:10.1038/nm1523 · Cited by 3,216
Kaufman, R. J. (1999) · Genes & Development · doi:10.1101/gad.13.10.1211 · Cited by 2,248
Roles of heat-shock proteins in innate and adaptive immunity.
Srivastava, P. (2002) · Nature reviews. Immunology · doi:10.1038/nri749 · Cited by 1,069
Self-citationCD91 Is a Common Receptor for Heat Shock Proteins gp96, hsp90, hsp70, and Calreticulin
Basu, S., Binder, R. J., Ramalingam, T., & Srivastava, P. K. (2001) · Immunity · doi:10.1016/s1074-7613(01)00111-x · Cited by 900
Self-citationMore than one reason to rethink the use of peptides in vaccine design
Purcell, A. W., McCluskey, J., & Rossjohn, J. (2007) · Nature Reviews Drug Discovery · doi:10.1038/nrd2224 · Cited by 860
Metadata
- Authors
- Basu, S., & Srivastava, P. K.
- Venue
- The Journal of Experimental Medicine
- Publisher
- Rockefeller University Press
- Published
- 1999-03-01
- Volume
- 189
- Issue
- 5
- Pages
- 797-802
- ISSN
- 0022-1007 (ISSN-L)
- 1540-9538
- OpenAlex
- W2123311867
- Cited by
- 252
- References
- 28
- FWCI
- 6.52
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.